MyLife Technologies developed a platform technology based on ceramic, nanoporous MicroNeedle Arrays (npMNA), which can be used for dermal delivery of a wide range of drugs. In general, our npMNA-patch technology could provide an attractive alternative for specific parenteral formulations, oral dosage forms or nasal delivery forms.
